Creative Planning Portfolio holdings
AUM
$171B
Turnover
10.62%
1-Year Est. Return
24.68%
This Fund
S&P 500
This Quarter
Est. Return
-0.2%
1 Year Est. Return
+24.68%
3 Year Est. Return
+62.17%
5 Year Est. Return
+55.89%
10 Year Est. Return
+171.9%
AUM
$147B
AUM Growth
+$7.72B
(+5.5%)
Cap. Flow
+$9.48B
Cap. Flow
% of AUM
6.43%
Top 10 Holdings %
Top 10 Hldgs %
41.95%
Holding
4,221
New
328
Increased
2,776
Reduced
891
Closed
131
Avg Time Held Equity + Options
4.2
years
Top 10 Avg Time Held Equity + Options
1.5
years
Top 20 Avg Time Held Equity + Options
4
years
Avg Time Held Equity only
4.2
years
Top 10 Avg Time Held Equity only
1.5
years
Top 20 Avg Time Held Equity only
4
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Short-Term Bond ETF
BSV
|
+$888M |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$700M |
| 3 |
State Street SPDR Portfolio Developed World ex-US ETF
SPDW
|
+$408M |
| 4 |
iShares Core US Aggregate Bond ETF
AGG
|
+$338M |
| 5 |
Vanguard Russell 1000 Value ETF
VONV
|
+$280M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$248M |
| 2 |
Schwab US Large- Cap ETF
SCHX
|
+$41.4M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$39.9M |
| 4 |
Schwab US Large-Cap Value ETF
SCHV
|
+$34.6M |
| 5 |
Schwab US Mid-Cap ETF
SCHM
|
+$32M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 75.77% |
| 2 | Technology | 8.02% |
| 3 | Financials | 3.7% |
| 4 | Industrials | 2.22% |
| 5 | Healthcare | 2.17% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
3226
Transcat
TRNS
$771M
| $388K | ﹤0.01% |
+5,278
| New | +$372K |
2026 Q1
0 quarters
|
|
3227
Icon
ICLR
$13B
| $387K | ﹤0.01% |
3,498
-880
| -20% | -$120K |
2015 Q3
42 quarters
|
|
3228
LSI Industries
LYTS
$749M
| $386K | ﹤0.01% |
20,757
+2,206
| +12% | +$45.5K |
2024 Q4
5 quarters
|
|
3229
Nuveen S&P 500 Dynamic Overwrite Fund
SPXX
$335M
| $385K | ﹤0.01% |
+23,963
| New | +$420K |
2026 Q1
0 quarters
|
|
3230
Lexeo Therapeutics
LXEO
$216M
| $385K | ﹤0.01% |
67,079
+56,721
| +548% | +$402K |
2025 Q4
1 quarter
|
|
3231
Ladder Capital
LADR
$1.09B
| $385K | ﹤0.01% |
39,387
+4,979
| +14% | +$52.3K |
2023 Q1
12 quarters
|
|
3232
Tectonic Therapeutic
TECX
$410M
| $385K | ﹤0.01% |
+12,446
| New | +$306K |
2026 Q1
0 quarters
|
|
3233
JPMorgan US Momentum Factor ETF
JMOM
$2.72B
| $384K | ﹤0.01% |
5,654
+29
| +0.5% | +$2.03K |
2023 Q4
9 quarters
|
|
3234
DELISTED
Apellis Pharmaceuticals
APLS
| $383K | ﹤0.01% |
9,521
-6,918
| -42% | -$149K |
2025 Q2
3 quarters
|
|
3235
AtriCure
ATRC
$2.91B
| $383K | ﹤0.01% |
13,419
+873
| +7% | +$29.8K |
2024 Q3
6 quarters
|
|
3236
Invesco Dorsey Wright SmallCap Momentum ETF
DWAS
$384M
| $380K | ﹤0.01% |
3,863
| – | – |
2023 Q4
9 quarters
|
|
3237
Phibro Animal Health
PAHC
$1.54B
| $380K | ﹤0.01% |
6,876
+1,344
| +24% | +$64K |
2025 Q3
2 quarters
|
|
3238
Tiptree Inc
TIPT
$629M
| $380K | ﹤0.01% |
+22,449
| New | +$384K |
2026 Q1
0 quarters
|
|
3239
Goldman Sachs Access Treasury 0-1 Year ETF
GBIL
$7.9B
| $380K | ﹤0.01% |
+3,791
| New | +$379K |
2026 Q1
0 quarters
|
|
3240
Vertex
VERX
$2.07B
| $379K | ﹤0.01% |
31,855
+3,270
| +11% | +$50.9K |
2025 Q4
1 quarter
|
|
3241
Farmland Partners
FPI
$460M
| $378K | ﹤0.01% |
33,698
+4,954
| +17% | +$56.8K |
2025 Q4
1 quarter
|
|
3242
Regional Management Corp
RM
$308M
| $378K | ﹤0.01% |
11,725
+5,741
| +96% | +$200K |
2025 Q3
2 quarters
|
|
3243
State Street SPDR Portfolio Short Term Treasury ETF
SPTS
$7.14B
| $377K | ﹤0.01% |
12,931
+2,321
| +22% | +$67.9K |
2022 Q4
13 quarters
|
|
3244
Cannae Holdings
CNNE
$688M
| $377K | ﹤0.01% |
+33,175
| New | +$445K |
2026 Q1
0 quarters
|
|
3245
Replimune Group
REPL
$1.07B
| $375K | ﹤0.01% |
49,081
+3,920
| +9% | +$30K |
2024 Q1
8 quarters
|
|
3246
Luxfer Holdings
LXFR
$466M
| $375K | ﹤0.01% |
30,817
+10,596
| +52% | +$147K |
2025 Q3
2 quarters
|
|
3247
iShares Large Cap Max Buffer Sep ETF
SMAX
$119M
| $375K | ﹤0.01% |
13,994
| – | – |
2025 Q1
4 quarters
|
|
3248
Vitamin Cottage Natural Grocers
NGVC
$712M
| $375K | ﹤0.01% |
+14,492
| New | +$374K |
2026 Q1
0 quarters
|
|
3249
First Trust SMID Cap Rising Dividend Achievers ETF
SDVY
$10.9B
| $372K | ﹤0.01% |
9,445
+1,084
| +13% | +$44K |
2024 Q4
5 quarters
|
|
3250
SelectQuote
SLQT
$59.5M
| $372K | ﹤0.01% |
591,589
+421,470
| +248% | +$443K |
2020 Q4
21 quarters
|
|
Similar funds
Creative Planning's Q1 2026 Portfolio in Review
As of Q1 2026, Creative Planning held 4,221 positions worth $147B, up 5.5% from $140B the previous quarter. Its ten largest holdings account for 42% of the portfolio.
Creative Planning deployed $9.48B of net new capital in Q1 2026, opening 328 new positions and adding to 2,776 existing holdings. Its largest new stake was Innovator US Equity Power Buffer ETF August: 270,134 shares worth $11.5M.
By sector, the portfolio is most concentrated in Miscellaneous at 76% of assets, down from 76% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Vanguard FTSE Developed Markets ETF, an estimated $248M trimmed.
- Creative Planning's largest Q1 2026 buy was Innovator US Equity Power Buffer ETF August: 270,134 shares worth $11.5M.
- Creative Planning added most to Vanguard Short-Term Bond ETF in Q1 2026, an estimated $888M increase.
- Creative Planning's biggest Q1 2026 reduction was Vanguard FTSE Developed Markets ETF, cutting an estimated $248M.
- Creative Planning fully exited CyberArk in Q1 2026, selling an estimated $9.29M.
- Creative Planning's ten largest holdings make up 42% of its $147B portfolio in Q1 2026.
- Creative Planning opened 328 new positions and closed 131 in Q1 2026.
- Creative Planning's portfolio value rose 5.5% quarter-over-quarter to $147B.
Based on Creative Planning's 13F filing for Q1 2026, filed 12 May 2026.